Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
Condition(s):Allogeneic Stem Cell TransplantationLast Updated:December 10, 2012Terminated
Hide Studies Not Open or Pending
Condition(s):Allogeneic Stem Cell TransplantationLast Updated:December 10, 2012Terminated
Condition(s):Cytomegalovirus InfectionLast Updated:September 21, 2011Completed
Condition(s):Giant Lymph Node HyperplasiaLast Updated:April 18, 2017Withdrawn
Condition(s):Cytomegalovirus InfectionsLast Updated:March 29, 2018Completed
Condition(s):Epstein-Barr Virus Associated Lymphoproliferative Disorder; EBV-Related PTLD; EBV Related Non-Hodgkin’s Lymphoma; EBV-Positive DLBCL, NOS; EBV Associated Lymphoma; EBV Related PTCL, NOSLast Updated:March 8, 2024Recruiting
Condition(s):Cytomegalovirus InfectionsLast Updated:February 7, 2011Completed
Condition(s):Transplantation Infection; Epstein-Barr Virus Infections; Cytomegalovirus InfectionsLast Updated:April 12, 2022Completed
Condition(s):Transplant Complication; CMVLast Updated:December 6, 2023Recruiting
Condition(s):HIV Infections; Cytomegalovirus InfectionsLast Updated:July 31, 2020Completed
Condition(s):Human Herpesvirus 8Last Updated:January 10, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.